BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...PDCD1; CD279) - Programmed cell death 1 TNFα - tumor necrosis factor α Hongjiang Li, Staff Writer Biosimilar trastuzumab...
BioCentury | Apr 16, 2020
Product Development

April 15 Quick Takes: TScan, Novartis team up on TCR therapies and a first for UroGen; plus Aligos, Leo, Madrigal, Merck

...IgE - Immunoglobulin E THRB - Thyroid hormone receptor β BioCentury Staff Ontruzant (Brand), SB3 (Compound #), biosimilar trastuzumab...
BioCentury | Jan 25, 2020
Company News

Pfizer seeking to dent market share with trio of discounted biosimilars

...EGFR2; ErbB2; neu) - Epidermal growth factor receptor 2 Paul Bonanos, Associate Editor Zirabev, biosimilar bevacizumab (PF-06439535) Trazimera, biosimilar trastuzumab...
BioCentury | Jul 19, 2019
Company News

July 19 Company Quick Takes: First biosimilars of Avastin, Herceptin launched; plus Gilenya, Celltrion-Nan Fung and Celgene

...rituximab-abbs (CT-P10) Gilenya, Imusera, fingolimod (FTY720, TDI-132) Herzuma, biosimilar trastuzumab-pkrb (CTP-6, CT-P6, CT-P26, CT-P06) Inflectra, Remsima, biosimilar infliximab-dyyb (CT-P13) Kanjinti, biosimilar trastuzumab...
BioCentury | Jun 15, 2019
Company News

June 13 Company Quick Takes: ISS rebuffs Takeda’s Weber; plus Sage, Blueprint, Tetraphase, Celgene and more

...Brand), MYL-1401O (Compound #), biosimilar trastuzumab (Generic), Ogivri (Other), Hertraz (Other), CANMab (Other) Pixuvri, pixantrone (BBR 2778) Trazimera, biosimilar trastuzumab...
BioCentury | Feb 15, 2019
Company News

Samsung Bioepis partners with AffaMed, expands biosimilar development in China

...Shanghai, China Business: Cancer, hematology, autoimmune Hongjiang Li biosimilar eculizumab (SB12) biosimilar ranibizumab (SB11) Ontruzant (Brand), SB3 (Compound #), biosimilar trastuzumab...
BioCentury | Jan 25, 2019
Clinical News

Samsung's Herceptin biosimilar gains U.S. approval

...Co. Ltd., Incheon, Korea Product: Ontruzant trastuzumab-dttb Business: Biosimilars, cancer Jennie Walters Ontruzant (Brand), SB3 (Compound #), biosimilar trastuzumab...
BioCentury | Jan 22, 2019
Company News

Samsung's Herceptin biosimilar gains U.S. approval

...between Biogen Inc. (NASDAQ:BIIB) and Samsung BioLogics Co. Ltd. (KOSDAQ:207940). Jennie Walters Ontruzant (Brand), SB3 (Compound #), biosimilar trastuzumab...
BioCentury | Dec 21, 2018
Clinical News

FDA approves Celltrion's Herceptin biosimilar

...Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), Petach Tikva, Israel Product: Herzuma biosimilar trastuzumab (CT-P6) Business: Cancer Sandi Wong Herzuma, biosimilar trastuzumab...
BioCentury | Dec 14, 2018
Company News

FDA approves Celltrion's Herceptin biosimilar

...lost W9,500 to W208,000 on Friday. The news came after market close in Korea. Sandi Wong Herzuma, biosimilar trastuzumab...
Items per page:
1 - 10 of 52